Tag: revascularisation
Baylis Medical Technologies announces first commercial use of PowerWire Pro for...
Baylis Medical Technologies today announced the completion of its first clinical use of the PowerWire Pro radiofrequency (RF) guidewire to safely cross a chronically...
Studies highlight need for tailored treatment options for women with peripheral...
New clinical results highlight the need for inclusive approaches and comprehensive examinations of treatment options for peripheral arterial disease (PAD), including endovascular therapy and...
CX 2024: Paclitaxel device restrictions “did cause harm”
“Unfortunately, we are doing worse for our patients today,” were the sobering thoughts of Eric Secemsky (Boston, United States) during a late-breaking presentation in...
BEST-CLI: One year on
A dedicated session at the 2023 VEITHsymposium (14–18 November, New York, USA) aimed to unpack the ways in which clinical practice and attitudes in...
Black patients nearly 50% less likely to receive revascularisation for PAD
A new study from Keck Medicine at the University of Southern California (USC; Los Angeles, USA) has uncovered “significant racial disparities” in the diagnosis, treatment and outcomes of...
New analysis of chronic limb-threatening ischaemia patients places BEST-CLI trial into...
A new analysis of chronic limb-threatening ischaemia (CLTI) treatment outcomes was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography &...
BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients
A question from Manj Gohel (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) on what the Charing Cross (CX) audience should take back to...
Distal embolic protection linked to significantly better outcomes in carotid stenting
Distal embolic protection using a filter has been associated with improved transfemoral carotid artery stenting (tfCAS) outcomes in terms of in-hospital stroke and death...
Equivalency to clinical practice “varies considerably” across recent carotid intervention trials
The external validity—in other words, the transferability to real-world clinical practice—of contemporary randomised controlled trials (RCTs) investigating carotid artery stenosis interventions “varies considerably”, as...
Endarterectomy and TCAR “continue to show superior outcomes” to transfemoral stenting
Researchers led by a vascular team in Indianapolis found that carotid endarterectomy (CEA) remains the most-used strategy in carotid revascularisation, with CEA and transcarotid...
Carotid stenosis in women: Should the approach differ?
The existing evidence on whether women with carotid stenosis experience inferior treatment outcomes compared to men is mixed—and this uncertainty is reflected in the...
Data from new VOYAGER PAD analyses reinforce benefit of Xarelto plus...
The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced data from new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the...
Study highlights need to extend scope of cerebrovascular health disparities research
A new research letter in Stroke outlines use of the novel National Institutes of Health (NIH) ‘All of Us’ research programme dataset of diverse...
Novel system-wide interdisciplinary team diverts patients from amputation and improves outcomes
Findings from a first-of-its-kind study conducted at University Hospitals (UH) Harrington Heart & Vascular Institute (Cleveland, USA) showed a novel system-wide interdisciplinary team assembled...
Study confirms efficiency of Upstream Peripheral’s GoBack catheter for complex lower...
Upstream Peripheral Technologies announced today that its GoBack catheter for crossing and re-entry was proven very effective for patients undergoing complex revascularisations in lower...
VOYAGER PAD subanalysis highlights risks for claudicants undergoing revascularisation
Principal investigator of the VOYAGER PAD trial, Marc Bonaca (University of Colorado Anschutz Medical Campus, Aurora, USA) speaks to Vascular News about the latest data...
Hispanic adults with PAD access inpatient care most often via the...
Hispanic adults hospitalised for treatment of symptoms of peripheral arterial disease (PAD) were more likely to access this care by going to the emergency...
Systematic review and meta-analysis finds “substantial” one-year mortality rate in octogenarians...
In octogenarians with chronic limb-threatening ischaemia (CLTI), researchers found a one-year mortality rate of 32% after revascularisation, which was significantly higher than in non-octogenarians....
ESC/ESVS consensus document gives clear recommendations for following up patients after...
New guidance on monitoring patients after revascularisation for peripheral arterial diseases (PAD) has been produced by the European Society of Cardiology (ESC) Working Group...
Full revascularisation “may not be the best solution” for CLI patients
Aiming for full revascularisation “may not be the best solution” for treating patients with critical limb ischaemia (CLI) according to Thomas Zeller (Bad Krozingen,...
ESVS 2019: HT-CLI trial to definitively test if cell technology can...
Bijan Modarai (London, UK) talks to BLearning Peripheral at ESVS 2019 (European Society for Vascular Surgery; 24–27 September; Hamburg, Germany) about the HT-CLI trial, which will look at the...
Customising therapy in femoropopliteal revascularisation
Gary Ansel (Columbus, USA) tells Vascular News at VEITHSymposium 2018 about how drug-based therapies have become a mainstay in femoropopliteal revascularisation and how interventionalists...
LINC 2018 data highlight IN.PACT Admiral as safe and effective treatment...
Medtronic added to its body of clinical evidence supporting the IN.PACT Admiral drug-coated balloon with new presentations that demonstrated durable and consistent clinical outcomes...
Surgery-first approach for CLI offers faster wound healing rate than endovascular...
A surgical-first strategy appears to be superior to endovascular treatment for critical limb ischaemia (CLI) revascularisation, exhibiting improved wound healing rate and overall healing...
LimFlow receives CE mark for percutaneous critical limb perfusion system
LimFlow has received CE mark for its fully percutaneous LimFlow system designed for venous arterialisation of the lower limbs in end-stage patients at risk...
